Table 3.
Number of patients with CKD achieving BP control to target
Time Point | Control | Intervention | Incidence Rate Ratio (95% CI) | |||
---|---|---|---|---|---|---|
Unadjusted | P Value | Adjusted | P Value | |||
Baseline | 6834/11,551 (59.2) | 7137/11,473 (62.2) | ||||
6 mo | 6801/11,428 (59.5) | 7006/11,259 (60.7) | 1.05 (1.01 to 1.08) | <0.01 | 1.04 (1.01 to 1.08) | 0.02 |
12 mo | 6856/11,174 (61.4) | 7364/11,373 (64.7) | 1.06 (1.02 to 1.09) | 0.001 | 1.05 (1.02 to 1.09) | <0.01 |
18 mo | 6777/10,979 (61.7) | 7341/11,250 (65.2) | 1.06 (1.02 to 1.09) | 0.001 | 1.05 (1.02 to 1.09) | <0.01 |
24 mo | 6921/10,778 (64.2) | 7275/11,023 (66.0) | 1.03 (0.99 to 1.06) | 0.10 | 1.02 (0.99 to 1.06) | 0.18 |
30 mo | 6586/10,488 (62.8) | 7128/10,735 (66.4) | 1.06 (1.02 to 1.09) | 0.001 | 1.05 (1.02 to 1.09) | 0.003 |
36 mo | 6711/10,169 (66.0) | 7076/10,392 (68.1) | 1.03 (1.00 to 1.07) | 0.07 | 1.03 (1.00 to 1.07) | 0.06 |
42 mo | 7460/11,129 (67.0) | 7295/10,689 (68.2) | 1.02 (0.99 to 1.05) | 0.28 | 1.02 (0.99 to 1.06) | 0.22 |
Values represent numbers meeting target per total patients with CKD (percentage of total). BP values were imputed using the last observation carried forward whenever no measurements were taken within a time period. If a patient died or moved to a different trial practice with the opposing treatment allocation, they were excluded from the analysis thereafter. 95% CI, 95% confidence interval.